Cellectar Biosciences, Inc. (CLRB) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 9.27M | 14.04M | 13.62M | 12.62M | 14.89M | 24.25M | 35.9M | 27.91M | 41.37M | 10.45M | 20.11M | 5.61M |
| Cash & Short-Term Investments | 8.35M | 13.2M | 12.55M | 11.04M | 13.91M | 23.29M | 34.26M | 25.87M | 40.03M | 9.56M | 18.99M | 5.15M |
| Cash Only | 8.35M | 13.2M | 12.55M | 11.04M | 13.91M | 23.29M | 34.26M | 25.87M | 40.03M | 9.56M | 18.99M | 5.15M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 920.04K | 842.43K | 0 | 0 | 987.5K | 961.66K | 1.64M | 2.04M | 1.34M | 888.23K | 1.12M | 456.68K |
| Total Non-Current Assets | 1.85M | 939.86K | 1.01M | 1.08M | 1.15M | 1.22M | 1.39M | 1.48M | 1.54M | 1.62M | 1.44M | 899.51K |
| Property, Plant & Equipment | 1.82M | 910.08K | 976.11K | 1.05M | 1.12M | 1.19M | 1.36M | 1.45M | 1.51M | 1.59M | 1.41M | 869.73K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 29.78K | 29.78K | 29.78K | 29.78K | 29.78K | 29.78K | 29.78K | 29.78K | 29.78K | 29.78K | 29.78K | 29.78K |
| Total Assets | 11.12M | 14.98M | 14.63M | 13.7M | 16.04M | 25.47M | 37.29M | 29.38M | 42.91M | 12.08M | 21.55M | 6.51M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -30.68% | -41.2% | -60.78% | -53.39% | -62.61% | 110.96% | 73.05% | 351.44% | 189.17% | -44.07% | 11.55% | -74.86% |
| Total Current Liabilities | 4.87M | 4.75M | 4.91M | 5.87M | 6.02M | 9.39M | 20.31M | 15.17M | 28.55M | 25.36M | 16.47M | 6.45M |
| Accounts Payable | 4.72M | 4.42M | 4.01M | 4.68M | 3.87M | 4.11M | 8.3M | 6.46M | 7.39M | 9.18M | 0 | 6.39M |
| Days Payables Outstanding | -3.74K | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 100.19K | 0 | 0 | 0 | 0 | 0 | 0 | 73.99K | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 149K | 226K | 801.65K | 1.1M | 2.06M | 4.59M | 11.93M | 8.63M | 21.08M | 16.12M | 16.41M | 0 |
| Current Ratio | 1.90x | 2.96x | 2.77x | 2.15x | 2.47x | 2.58x | 1.77x | 1.84x | 1.45x | 0.41x | 1.22x | 0.87x |
| Quick Ratio | 1.90x | 2.96x | 2.77x | 2.15x | 2.47x | 2.58x | 1.77x | 1.84x | 1.45x | 0.41x | 1.22x | 0.87x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.53M | 309.4K | 335.89K | 361.49K | 1.77M | 1.79M | 1.81M | 453.51K | 474.35K | 494K | 18.43M | 530.86K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 1.53M | 309.4K | 335.89K | 361.49K | 386.2K | 409.59K | 431.93K | 453.51K | 474.35K | 494K | 512.75K | 530.86K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 1.38M | 1.38M | 1.38M | 0 | 0 | 0 | 17.92M | 0 |
| Total Liabilities | 6.4M | 5.06M | 5.25M | 6.23M | 7.79M | 11.18M | 22.13M | 15.62M | 29.03M | 25.85M | 34.9M | 6.98M |
| Total Debt | 1.53M | 409.59K | 431.93K | 453.51K | 474.35K | 494K | 512.75K | 530.86K | 548.34K | 552.98K | 569.01K | 584.5K |
| Net Debt | -6.82M | -12.79M | -12.12M | -10.59M | -13.43M | -22.79M | -33.75M | -25.34M | -39.48M | -9.01M | -18.42M | -4.57M |
| Debt / Equity | 0.32x | 0.04x | 0.05x | 0.06x | 0.06x | 0.03x | 0.03x | 0.04x | 0.04x | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 4.72M | 9.92M | 9.38M | 7.47M | 8.25M | 14.29M | 15.16M | 13.76M | 13.88M | -13.78M | -13.35M | -467K |
| Equity Growth % | -42.85% | -30.61% | -38.15% | -45.75% | -40.55% | 203.76% | 213.57% | 3047.08% | 89.29% | -244.48% | -204.72% | -102.31% |
| Book Value per Share | 1.11 | 2.34 | 2.97 | 4.64 | 5.37 | 10.23 | 11.57 | 11.03 | 14.19 | -21.28 | -35.42 | -1.24 |
| Total Shareholders' Equity | 4.72M | 9.92M | 9.38M | 7.47M | 8.25M | 14.29M | 15.16M | 13.76M | 13.88M | -13.78M | -13.35M | -467K |
| Common Stock | 42 | 42 | 32 | 18 | 461 | 461 | 406 | 358 | 332 | 207 | 99 | 97 |
| Retained Earnings | -274.79M | -269.13M | -263.84M | -259.39M | -253.95M | -247.34M | -244.99M | -230.32M | -229.4M | -202.76M | -210.03M | -196.3M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |